The purpose of the Boston University Alzheimer's Disease Core Center (BU) ADCC) is to promote research concerning Alzheimer's Disease (AD) at Boston University and throughout the country by providing information and materials from well characterized and unique patient and caregiver populations: the ambulatory and late-stage suburban population at the Bedford VA Medical Center and the racially, ethnically, and culturally diverse poor urban population served by the Boston University Hospital Home Medical Service (HMS). All patients enrolled in the Clinical Core will be assessed every six months with a comprehensive neuropsychological test battery. A neurological examination will be performed annually and blood will be obtained to isolate DNA for molecular genetic studies and stored. A detailed family history will be obtained and caregivers will be assessed yearly. The database will allow for longitudinal comparisons and the ability to correlate the progression of AD with its impact on caregivers. The Neuropathology Core will establish accurate pathological diagnoses, rigorous documentation and quantitation of neuropathological changes, produce endothelial cell lines, and collect, store and disburse postmortem tissues. The Education and Information Transfer Core will provide a comprehensive program of AD research development, dissemination, and utilization for professional caregivers with respect to symptom management. The BU ADCC will fund pilot projects to promote new AD research and foster the development of new AD investigators. The BU ADCC will closely cooperate with, and complement, the Massachusetts Alzheimer's Disease Research Center and other national Alzheimer centers. These multiple activities will be coordinated by the Administrative Core. Research in AA at Boston University is substantial in all areas, from basic molecular biology through health services research. The ADCC will strengthen existing research and create new research alliances across BU sites. It will greatly facilitate basic research on the pathogenesis of AD, applied research on patient management strategies, and research concerning the impact of disease burden on caregivers and society. In addition, it will help foster the integration of basic and applied research to better understand the biological basis of clinical symptoms.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013846-04
Application #
6029813
Study Section
Special Emphasis Panel (ZAG1-DAG-4 (30))
Project Start
1996-07-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Boston University
Department
Neurology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Alosco, Michael L; Tripodis, Yorghos; Fritts, Nathan G et al. (2018) Cerebrospinal fluid tau, A?, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration. Alzheimers Dement 14:1159-1170
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Guan, Yue; Roter, Debra L; Wolff, Jennifer L et al. (2018) The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease. Patient Educ Couns 101:817-823
Li, Jinlei; Ogrodnik, Matthew; Devine, Sherral et al. (2018) Practical risk score for 5-, 10-, and 20-year prediction of dementia in elderly persons: Framingham Heart Study. Alzheimers Dement 14:35-42
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487

Showing the most recent 10 out of 791 publications